Fundraising for CFer awaiting double lung transplant

It is that time of year again. For the second year in a row I am promoting a Standup Comedy show to raise money for CF and / or CF Patients. This year we are raising money for Team TLC. Team TLC is a team comprised of friends and family of Terry Lee Carroll. Terry is a 32 year old CF patient who is currently awaiting a double lung transplant. Terry lives in Southgate, KY; just a short distance across the river and a couple miles from Cincinnati, OH. During his wait, he and his family will need to make several trips to the Cleveland Clinic, where he will eventually have his surgery. As you can imagine the financial burden this can cause is tremendous. All proceeds from Laugh Hard &Breathe Easy this year will go to Team TLC ( Terry). The show will be at the Newport Syndicate on Friday, July 12, 2013 @ 8:00pm. Tickets are $15 each or 2 for $25. There will be six local comedians including myself performing. Come out for what is guaranteed to be a great night. The Newport Syndicate will have a menu available and bar service as well. For details, tickets, or to make donations, please contact me @ 513-382-9057 or email me Thank you all in advance for your support and generosity!
Source: Cystic Fibrosis Transplants Forum - Category: Respiratory Medicine Authors: Tags: Transplants Source Type: forums

Related Links:

Chronic lung infection with the opportunistic pathogen Pseudomonas aeruginosa (PA) is common in patients with cystic fibrosis (CF) due to reduced mucociliary clearance and is the major contributor to mortality in CF [1]. Colonisation occurs in the paranasal sinuses where the inflammation is predominantly mediated by non-phlogistic immunoglobulin A (IgA) and from where PA is aspirated to the lungs. PA in CF patients is located in the airways and not systemically due to the aerobic conditions in combination with the reduced clearance of mucus in CF making the lungs and sinuses the ideal growth places for PA [2].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Tags: Original Article Source Type: research
This study sought to evaluate the EFA profile in both the plasma and erythrocyte membrane according to lung status by comparing CF patients with or without a lung transplant.A total of 50 homozygous F508del patients (33 CF patients [CF group] and 17 CF patients with a lung transplant [TX CF group]) were included. In comparison with the CF group, in the plasma, the levels of total n-3, α-linolenic, eicosapentaenoic, and docosahexaenoic acids were higher and the n-6/n-3 ratio was lower in the TX CF group. Yet, these differences were not observed in the erythrocyte membrane. This study supports that lung transplantation...
Source: Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) - Category: Lipidology Source Type: research
UNDERWEIGHT PATIENTS WITH CYSTIC FIBROSIS HAVE ACCEPTABLE SURVIVAL AFTER LUNG TRANSPLANTATION: A UNOS REGISTRY STUDY. Chest. 2020 Jan 17;: Authors: Ramos KJ, Kapnadak SG, Bradford MC, Somayaji R, Morrell ED, Pilewski JM, Lease ED, Mulligan MS, Aitken ML, Gries CJ, Goss CH Abstract BACKGROUND: Reduced body mass index (BMI) is an absolute contraindication for lung transplantation (LTx) at most centers in the United States (US). Our objective was to quantify post-LTx survival of moderate-to-severely underweight cystic fibrosis (CF) patients (BMI
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
Conclusions: ULT program allows transplantation in a significant percentage of patients with acceptable results. Pre-operative recipient selection is mandatory to improve clinical outcomes. PMID: 31903264 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
Semin Respir Crit Care Med 2019; 40: 842-856 DOI: 10.1055/s-0039-3399554Cystic fibrosis (CF) remains the most common indication for lung transplantation in children and the third most common in adults and has the highest median survival posttransplant for all pretransplant diagnoses. Criteria for transplant in patients with CF vary widely among transplant centers and early referral to multiple centers may be needed to maximize opportunities for lung transplantation. Comorbidities unique to CF such as resistant and atypical pathogens like Burkholderia and Mycobacterium abscessus, and cirrhosis require special consideration ...
Source: Seminars in Respiratory and Critical Care Medicine - Category: Respiratory Medicine Authors: Tags: Review Article Source Type: research
Conclusions: Therapeutic drug monitoring-guided meropenem may be a sound new therapeutic option in eradicating multidrug resistant Acinetobacter and offer a novel therapeutic option in the field of personalized medicine. PMID: 31871885 [PubMed]
Source: Respiratory Care - Category: Respiratory Medicine Authors: Tags: Respir Med Case Rep Source Type: research
Authors: Bouchara JP, Le Govic Y, Kabbara S, Cimon B, Zouhair R, Hamze M, Papon N, Nevez G Abstract Introduction: Considered for a long time to be exclusively responsible for chronic localized infections, fungi of the genus Scedosporium have recently received a renewed interest because of their recognition as common colonizing agents of the respiratory tract of patients with cystic fibrosis, and of the description of severe disseminated infections in patients undergoing lung transplantation. Recently, several studies have been carried out on these opportunistic pathogens, which led to some advances in the understan...
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
Cystic Fibrosis (CF) is a genetic disorder caused by mutations in the gene that encodes for the Cystic Fibrosis Transmembrane Regulator (CFTR) protein, an epithelial ion channel that is crucial in regulating the flow of negatively charged ions across membranes and ensuring adequate hydration of mucus [1]. As a consequence, dysfunction results in a multisystem disorder that seriously impacts upon on the lungs, eventually leading to death or the need for lung transplantation. Lumacaftor/ivacaftor (LUM/IVA) is a combination agent that targets CFTR.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Tags: Original Article Source Type: research
AbstractThe contribution of T-cells after lung transplant (LTx) remains controversial with no current consensus of their role concerning chronic lung allograft dysfunction. Using flow cytometry to assess T-cell subsets of bronchoalveolar lavage fluid (BALF) in 16 cystic fibrosis (CF) LTx recipients, we identified a decline in CD4+ T-cell frequency and an increase in CD8+ T-cell frequency in patients who developed severe bronchiolitis obliterans syndrome (BOS) (N = 10) when comparing baseline (6 months post-LTx) and follow-up (most recent bronchoscopy—clinical or surveillance per protocol). Comparin...
Source: Lung - Category: Respiratory Medicine Source Type: research
‘First step’ to better outcomes for cystic fibrosis Related items fromOnMedica Lung experts call for ‘national plan for lung cancer’ Smokers ’ lungs should remain as transplant option COPD patients need better tailored care Antibiotic fails to improve lung function in children with CF Sweet and fruity e-cigs linked to prolonged teenage vaping
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Cystic Fibrosis | Fundraising | Lung Transplant | Men | Respiratory Medicine | Transplant Surgery | Transplants